Demand for Lenacapavir, a new twice-yearly HIV prevention injection, is currently exceeding supply in the country, according to the Ministry of Health. The injection has proven particularly popular with men seeking preventative treatment. Initially, 19,200 doses were distributed to 103 health facilities nationwide following the program’s April launch. The unexpectedly high demand indicates significant interest in this new preventative method. Health officials are now facing logistical challenges in meeting the needs of those seeking access to the drug. Further details regarding resupply efforts have not yet been released. The situation highlights the importance of anticipating public health needs for newly available treatments.